← Open Payments lookup

AUDREY ALBRACHT: Open Payments

NPI 1992412811 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$527 in 22 payments from 12 companies in 2025. Trend: 2023 $472 · 2024 $382 · 2025 $527

Food & beverage: $527
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$111
Janssen Biotech, Inc.3$61
Novartis Pharmaceuticals Corporation2$59
SOBI, INC3$59
Regeneron Healthcare Solutions, Inc.2$55
AXOGEN1$36
Merck Sharp & Dohme LLC2$29
Novocure Inc.1$27
JAZZ PHARMACEUTICALS INC.1$25
Geron Corporation1$24

Products named: KISQALI, ENHERTU, LIBTAYO, RYBREVANT, Vonjo, IMFINZI, Optune Gio, ZEPZELCA.

Industry payments across TX — which companies pay providers there.